Showing results (131-140 of 230) with videos related to
Sort By:
Pageof 23
Thrombosis and Haemostasis|December 15, 1986
Heparin-induced osteoporosis in ratsT Mätzsch, D Bergqvist, U Hedner, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2013
Progressive improvement in wound healing with increased therapy in haemophilia B miceD M Monroe, M Hoffman, H R Roberts, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|July 15, 2000
Plasma lipoproteins enhance tissue factor-independent factor VII activationM Kjalke, A Silveira, A Hamsten, et al.Thrombosis Research|July 15, 1986
The influence of ketanserin on hemostasis in vitroD Bergqvist, S Arvidsson, U Haglund, et al.Surgery, Gynecology & Obstetrics|September 1, 1986
The influence of dextran and saline solution upon platelet behavior after microarterial anastomosisJ B Wieslander, P Dougan, U Stjernquist, et al.The British Journal of Surgery|July 1, 1987
Late ischaemic sequelae after umbilical artery catheterizationD Bergqvist, S E Bergentz, G Hermansson, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|August 8, 2009
Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditionsM N Aljamali, M Kjalke, U Hedner, et al.Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in ratsB Lauritzen, U Hedner, P B Johansen, et al.Haemostasis|January 1, 1996
Does glycosylation influence the experimental antithrombotic effect of a two-domain tissue factor pathway inhibitor?J Holst, B Lindblad, O Nordfang, et al.Haemostasis|January 1, 1989
Clinical experience with human plasma-derived factor VIIa in patients with hemophilia A and high titer inhibitorsU Hedner, S Bjoern, S S Bernvil, et al.Pageof 23